NCT07131631View on ClinicalTrials.gov

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Heart Failure and Reduced Ejection FractionFunctional Mitral Regurgitation
Interventions
DIAGNOSTIC_TEST

Cardiac MRI

Clinically indicated baseline CMR study with contrast up to 90 days before TEER procedure, including KCCQ questionnaire. At 6 months, participants will return for repeat of KCCQ, CMR study and a transthoracic echocardiogram. Blood samples, done as standard clinical care for hemotocrit for ECV calculation, will be obtained.

Trial Locations (6)

10029

ENROLLING_BY_INVITATION

Mount Sinai Fuster Heart Hospital, New York

22042

ENROLLING_BY_INVITATION

Inova Fairfax Medical Campus, Falls Church

28204

ENROLLING_BY_INVITATION

Sanger Heart and Vascular Institute, Charlotte

44195

ENROLLING_BY_INVITATION

Cleveland Clinic, Cleveland

45219

ENROLLING_BY_INVITATION

The Christ Hospital Health Network, Cincinnati

55407

RECRUITING

Minneapolis Heart Institute Foundation, Minneapolis

All Listed Sponsors
lead

Minneapolis Heart Institute Foundation

OTHER